E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/29/2007 in the Prospect News PIPE Daily.

New Issue: Rockwell Medical pockets $12.95 million from placement of units

By Devika Patel

Knoxville, Tenn., Nov. 29 - Rockwell Medical Technologies, Inc. has raised $12.95 million from a private placement of units.

The company sold 2,158,337 units at $6.00 apiece. Each unit consists of one common share and one half-share warrant. The warrants are exercisable at $7.18.

Proceeds will be used for development of the company's iron maintenance therapy drug SFP (soluble ferric pyrophosphate).

Wixom, Mich.-based Rockwell Medical is a manufacturer and developer of renal drug therapies.

Issuer:Rockwell Medical Technologies, Inc.
Issue:Units of one common share and one half-share warrant
Amount:$12,950,022
Units:2,158,337
Price:$6.00
Warrants:One half-share warrant per unit
Warrant strike price:$7.18
Settlement date:Nov. 29
Stock symbol:Nasdaq: RMTI
Stock price:$7.50 at close Nov. 28

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.